Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.18), Zacks reports. The business had revenue of $53.80 million for the quarter. Bioceres Crop Solutions had a negative return on equity of 41.35% and a negative net margin of 94.76%.
Bioceres Crop Solutions Stock Performance
Shares of BIOX stock traded down $0.01 during trading hours on Thursday, reaching $0.22. The company had a trading volume of 19,089 shares, compared to its average volume of 468,307. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.62 and a current ratio of 0.80. The firm has a market cap of $13.98 million, a PE ratio of -0.06 and a beta of 0.54. Bioceres Crop Solutions has a one year low of $0.19 and a one year high of $1.88. The business has a fifty day moving average price of $0.32 and a 200-day moving average price of $0.44.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Bioceres Crop Solutions currently has a consensus rating of “Reduce” and an average price target of $2.00.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions. Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.
Read More
- Five stocks we like better than Bioceres Crop Solutions
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
